Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) Operating Expenses (2016 - 2026)

Rockwell Medical filings provide 16 years of Operating Expenses readings, the most recent being $3.7 million for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 12.97% to $3.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.0 million, a 0.67% decrease, with the full-year FY2025 number at $14.0 million, down 0.67% from a year prior.
  • Operating Expenses hit $3.7 million in Q4 2025 for Rockwell Medical, up from $3.3 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $6.1 million in Q2 2021 to a low of $2.9 million in Q4 2023.
  • Median Operating Expenses over the past 5 years was $3.7 million (2022), compared with a mean of $4.1 million.
  • Biggest five-year swings in Operating Expenses: surged 35.79% in 2021 and later tumbled 39.27% in 2023.
  • Rockwell Medical's Operating Expenses stood at $5.3 million in 2021, then decreased by 24.74% to $4.0 million in 2022, then decreased by 27.46% to $2.9 million in 2023, then grew by 15.27% to $3.3 million in 2024, then increased by 12.97% to $3.7 million in 2025.
  • The last three reported values for Operating Expenses were $3.7 million (Q4 2025), $3.3 million (Q3 2025), and $3.3 million (Q2 2025) per Business Quant data.